VOGLIDIN M.3
VOGLIDIN M.3 contains Voglibose 0.3 mg + Metformin 500 mg, a dual-action combination designed to control type 2 diabetes effectively, especially after meals. Voglibose delays carbohydrate digestion to reduce post-meal sugar spikes, while Metformin lowers liver glucose production and improves insulin sensitivity. This combination helps achieve better blood sugar stability and supports long-term glycemic control in diabetic patients.
Related products
SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP Eq to Sitagliptin...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively....
DUET ACT 4
DUET ACT 4 Tablet is a combination medicine used for effective management of type 2...
DUET ACT 3
DUET ACT 3 Tablet is a combination medicine used for managing type 2 diabetes. It...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
DAPAGLIDE 10
COMPOSITION : Dapagliflozin 10 mg
GLIDA 2
Composition : glimepiride 40 mg
